S&P 500
(0.80%) 5 277.51 points

Dow Jones
(1.51%) 38 686 points

Nasdaq
(-0.01%) 16 735 points

Oil
(-0.94%) $77.18

Gas
(0.35%) $2.58

Gold
(-0.79%) $2 347.70

Silver
(-3.10%) $30.56

Platinum
(0.63%) $1 044.50

USD/EUR
(-0.17%) $0.921

USD/NOK
(-0.49%) $10.49

USD/GBP
(-0.05%) $0.785

USD/RUB
(0.15%) $90.40

Realtime updates for Applied Therapeutics Inc [APLT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Upcoming Earnings Alert

5 days till quarter result
(tns 2024-06-06)

Expected move: +/- 12.49%

BUY

71.43%
return 7.95%

SELL

14.29%
return 22.32%

Last Updated31 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

-2.73% $ 4.28

BUY 154381 min ago

@ $2.66

Issued: 14 Feb 2024 @ 14:44

Return: 60.90%

Previous signal: Feb 14 - 13:41

Previous signal: Sell

Return: -3.45 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications...

Stats
Today's Volume	767 455
Average Volume	922 796
Market Cap	489.06M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $-0.160 ) 2024-06-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.24
ATR14	$0.00900 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-12	Hooks Corwin Dale	Buy	300 000	Common Stock
2024-04-12	Hooks Corwin Dale	Buy	0
2024-03-14	Shendelman Shoshana	Sell	318 573	Common Stock
2024-03-14	Perfetti Riccardo	Sell	110 804	Common Stock
2024-03-14	Hansard Adam	Sell	48 871	Common Stock

INSIDER POWER
37.52
Last 97 transactions
Buy: 24 985 894 \| Sell: 4 549 161

Volume Correlation

Long: -0.49 (neutral)

Short: -0.20 (neutral)

Signal:(35.748) Neutral

Applied Therapeutics Inc Correlation

10 Most Positive Correlations
OZEM	1
EQ	0.934
MSAQX	0.933
EVCGX	0.93
FSMSX	0.93
MAMA	0.925
NBBK	0.925
ORGN	0.924
KARRX	0.92
BULIX	0.919

10 Most Negative Correlations
HDL	-0.978
BAER	-0.945
NWGL	-0.943
QREARX	-0.942
HTOOW	-0.927
PLTN	-0.918
GGLS	-0.918
BRLSW	-0.916
CLMB	-0.915
RDZN	-0.909

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Applied Therapeutics Inc Correlation - Currency/Commodity

0.57
( weak )

0.67
( moderate )

0.00
( neutral )

-0.42
( neutral )

0.08
( neutral )

-0.73
( moderate negative )

Applied Therapeutics Inc Financials

Annual	2023
Revenue:	$9.99M
Gross Profit:	$9.64M (96.47 %)
EPS:	$-1.420

FY	2023
Revenue:	$9.99M
Gross Profit:	$9.64M (96.47 %)
EPS:	$-1.420

FY	2022
Revenue:	$0
Gross Profit:	$-441 000 (0.00 %)
EPS:	$-2.16

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-4.12

Financial Reports:

No articles found.

Applied Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Applied Therapeutics Inc

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.

Total Execution Time: 1.6395270824432 seconds
Number of API calls: 2
Number of DB calls: 8